Related Experiment Video
Updated: Apr 25, 2026

06:38
A Syngeneic Mouse Model of Metastatic Renal Cell Carcinoma for Quantitative and Longitudinal Assessment of Preclinical Therapies
Published on: April 12, 2017
13.0K
Metastasis-Initiating Cells in Renal Cancer
Mohammed I Khan1, Anna M Czarnecka1, Renata Duchnowska1
1Molecular Oncology Laboratory, Clinic of Oncology, Military Institute of Medicine, ul. Szaserów 128, 04-141 Warsaw, Poland.
Current Signal Transduction Therapy
|August 26, 2014
Summary
Metastasis-initiating cells (MICs) in renal cell carcinoma may drive cancer spread via circulation. Understanding MICs
Area of Science:
- Oncology
- Cancer Biology
- Molecular Pathology
Background:
- Metastasis involves cancer cells spreading from the primary tumor to distant sites via circulation.
- Circulating tumor cells (CTCs) may harbor specialized metastasis-initiating cells (MICs) originating from the primary tumor.
- The role of MICs in renal cell carcinoma (RCC) metastasis is hypothesized but not extensively proven.
Purpose of the Study:
- To review existing studies on MICs and their gene expression profiles in renal cancer.
- To explore the potential role of MICs in initiating RCC metastasis.
- To identify molecular phenotypes of MICs for potential therapeutic strategies.
Main Methods:
- Literature review of studies investigating MICs in renal cancer.
- Analysis of research on circulating tumor cells (CTCs) and associated markers.
- Examination of findings from mouse xenograft models involving MIC transplantation.
Main Results:
- MICs are hypothesized to circulate in blood and bone marrow, initiating RCC metastasis.
- Specialized markers on circulating cells may identify MICs.
- Mouse models demonstrate MICs' potential to cause metastasis upon transplantation.
Conclusions:
- MICs are critical for understanding and potentially targeting RCC metastasis.
- Further research is needed to confirm the existence and role of MICs in human RCC.
- Identifying MIC molecular phenotypes could lead to novel therapeutic interventions for renal cancer.
Keywords:
Circulating tumour cellsmetastasis-initiating cellsrenal cell carcinomatumour-initiating cells.More Related Videos
Related Concept Videos
Metastasis
5.4K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
5.4K
Cancer Stem Cells and Tumor Maintenance
4.3K
Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
4.3K
Cancer Cell Migration through Invadopodia
2.4K
Invadosome is a broad category of cell surface structures with proteolytic activity that degrades the extracellular matrix (ECM). Invadosomes are present in normal cell types, including macrophages, endothelial cells, and neurons, as well as tumor cells. Although the macrophage podosomes and tumor cell invadopodia are classified as invadosomes, they have different structures, molecular pathways, and functions. Podosomes are short structures that last for a few minutes. However,...
2.4K
Adaptive Mechanisms in Cancer Cells
5.7K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.7K
Cancers Originate from Somatic Mutations in a Single Cell
12.4K
Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
12.4K

